In a study conducted in the USA, Lockett et al. 47 found that PARP1 Val762Ala genetic variant contributes to prostate cancer susceptibility and alters ADPRT/PARP-1 enzyme function in response to oxidative damage. Here, PARP1 is linked to prostate cancer.